Found: 10 articles
Article | Edition |
---|---|
Kravchenko A.V., Ladnaia N.N., Pokrovsky V.V., Kozyrina N.V., Yurin O.G., Sokolova E.V., Chekryzhova D.G.
Causes of death in people infected with the human immunodeficiency virus
|
№3 / 2023 |
Tuaeva R.G., Loseva O.K., Mazus A.I., Nagibina M.V., Bessarab T.P., Vengerov Yu.Ya.
Cardiovascular disease in HIV infection
|
№1 / 2023 |
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Goliusova M.D., Kulabukhova E.I., Kanestri V.G., Kozyrina N.V., Mityurina E.V.
The efficiency and safety of ART after switching patients to the combined Russian NRTI phosphaladine in combination with elsulfavirine
|
№3 / 2022 |
Kanestri V.G., Kravchenko A.V., Pokrovskaya A.V., Kulabukhova E.I., Kuimova U.A., Goliusova M.D., Kozyrina N.V., Shakhgildyan V.I., Yurin O.G.
Randomized, open-label, controlled, comparative study on switching HIV-infected patients with their antiretroviral therapy experience to a DTG and 3TC regimen: 96-weeks results
|
№4 / 2021 |
Kravchenko A.V., Kuimova U.A., Kanestri V.G., Goliusova M.D., Kulabukhova E.I.
The clinical course of HIV/COVID-19 co-infection and approaches to its therapy
|
№4 / 2021 |
Kravchenko A.V., Pokrovskaya A.V., Kuimova U.A., Kanestri V.G., Deulina M.O., Goliusova M.D., Kulabukhova E.I., Kozyrina N.V., Yurin O.G.
Results of treatment with a 60-week Russian ART regimen in patients with HIV infection
|
№3 / 2021 |
Yurin O.G., Ladnaia N.N., Kravchenko A.V., Sokolova E.V., Suvorova Z.K., Narsiya R.S., Pokrovsky V.V.
Antiretroviral therapy in Russia
|
№3 / 2021 |
Yurin O.G., Ladnaia N.N., Kozyrina N.V., Kravchenko A.V., Narsia R.S., Sokolova E.V., Dementyeva L.A., Pokrovsky V.V.
Quality of antiretroviral therapy in 2008–2018
|
№3 / 2020 |
Ladnaia N.N., Pokrovsky V.V., Kozyrina N.V., Sokolova E.V., Dementyeva L.A.
Human immunodeficiency virus-related mortality in the Russian Federation in 1987–2018
|
№3 / 2020 |
Kravchenko A.V., Orlova-Morozova E.A., Shimonova T.E., Kozyrev O.A., Nagimova F.I., Zakharova N.G., Ivanova E.S., Sonin D.B., Chernova O.E., Tonkikh O.S., Yakovlev A.A., Kurina N.V., Pokrovsky V.V., Bychko V.V., Vostokova N.V., Zozulya O.V.
The efficacy and safety of Elpivirine as part of a 24-48-week antiretroviral therapy regimen versus an Efavirenz-containing regimen
|
№5 / 2016 |